Local renal complement C3 induction by donor brain death is associated with reduced renal allograft function after transplantation

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2345-2354

  Damman, Jeffrey ^a   Nijboer, Willemijn N ^a   Schuurs, Theo A ^a   Leuvenink, Henri G ^a   Morariu, Aurora M ^b   Tullius, Stefan G ^b   Van Goor, Harry ^c   Ploeg, Rutger J ^a   Seelen, Marc A ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Department of Pathology and Medical Biology ^*  (Netherlands)

Author keywords

brain death; complement; kidney; transplantation

Indexed keywords

ACUTE PHASE PROTEIN; COMPLEMENT COMPONENT C3; FIBRINOGEN; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BRAIN DEATH; CONTROLLED STUDY; CRYOPRESERVATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY PROXIMAL TUBULE; KIDNEY TRANSPLANTATION; LIVING DONOR; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REPERFUSION;

ADULT; ANIMALS; BLOTTING, WESTERN; BRAIN DEATH; COLD ISCHEMIA; COMPLEMENT ACTIVATION; COMPLEMENT C3; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; KIDNEY TRANSPLANTATION; KIDNEY TUBULES; LIVING DONORS; MALE; MIDDLE AGED; PROGNOSIS; RATS; RATS, INBRED F344; RECEPTORS, COMPLEMENT; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; RNA, MESSENGER; TISSUE AND ORGAN HARVESTING;

EID: 79959963948     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq717     Document Type: Article

References (55)

1. Terasaki PI, Cecka JM, Gjertson DWet al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-336.
2. Herijgers P, Leunens V, Tjandra-Maga TB et al. Changes in organ perfusion after brain death in the rat and its relation to circulating catecholamines. Transplantation 1996; 62: 330-335. (Pubitemid 26277337)
3. Arita K, Uozumi T, Oki S et al. The function of the hypothalamopituitary axis in brain dead patients. Acta Neurochir (Wien) 1993; 123: 64-75. (Pubitemid 23240675)
4. Mertes PM, el Abassi K, Jaboin Y et al. Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation 1994; 58: 414-418. (Pubitemid 24271527)
5. Lopau K, Mark J, Schramm L et al. Hormonal changes in brain death and immune activation in the donor. Transpl Int 2000; 13: S282-S285.
6. Segel LD, vonHaag DW, Zhang J et al. Selective overexpression of inflammatory molecules in hearts from brain-dead rats. J Heart Lung Transplant 2002; 21: 804-811. (Pubitemid 34718186)
7. Takada M, Nadeau KC, Hancock WW et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65: 1533-1542. (Pubitemid 28304585)
8. van der Hoeven JA, Ploeg RJ, Postema F et al. Induction of organ dysfunction and up-regulation of inflammatory markers in the liver and kidneys of hypotensive brain dead rats: a model to study marginal organ donors. Transplantation 1999; 68: 1884-1890. (Pubitemid 30027342)
9. van der Hoeven JA, Ter Horst GJ, Molema G et al. Effects of brain death and hemodynamic status on function and immunologic activation of the potential donor liver in the rat. Ann Surg 2000; 232: 804-813.
10. Schuurs TA, Morariu AM, Ottens PJ et al. Time-dependent changes in donor brain death related processes. Am J Transplant 2006; 6: 2903-2911.
11. Kusaka M, Pratschke J, Wilhelm MJ et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405-410. (Pubitemid 30118123)
12. Hoeger S, Reisenbuechler A, Gottmann U et al. Donor dopamine treatment in brain dead rats is associated with an improvement in renal function early after transplantation and a reduction in renal inflammation. Transpl Int 2008; 21: 1072-1080.
13. Amado JA, Lopez-Espadas F, Vazquez-Barquero A et al. Blood levels of cytokines in brain-dead patients: relationship with circulating hormones and acute-phase reactants. Metabolism 1995; 44: 812-816.
14. Hans VH, Kossmann T, Joller H et al. Interleukin-6 and its soluble receptor in serum and cerebrospinal fluid after cerebral trauma. NeuroReport 1999; 10: 409-412. (Pubitemid 29104822)
15. Stangl M, Zerkaulen T, Theodorakis J et al. Influence of brain death on cytokine release in organ donors and renal transplants. Transplant Proc 2001; 33: 1284-1285. (Pubitemid 32237847)
16. Weiss S, Kotsch K, Francuski M et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 2007; 7: 1584-1593. (Pubitemid 46776248)
17. Fassbender K, Rossol S, Kammer T et al. Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of disease. J Neurol Sci 1994; 122: 135-139. (Pubitemid 24097260)
18. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454. (Pubitemid 29084777)
19. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80. (Pubitemid 24049800)
20. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181: 257-266. (Pubitemid 27156836)
21. Schultz DR, Arnold PI. Properties of four acute phase proteins: Creactive protein, serum amyloid A protein, alpha 1-acid glycoprotein, and fibrinogen. Semin Arthritis Rheum 1990; 20: 129-147.
22. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008; 454: 428-435.
23. Kalmovarin N, Friedrichs WE, O'Brien HV et al. Extrahepatic expression of plasma protein genes during inflammation. Inflammation 1991; 15: 369-379.
24. Geiger T, Andus T, Klapproth J et al. Induction of rat acute-phase proteins by interleukin 6 in vivo. Eur J Immunol 1988; 18: 717-721.
25. Andus T, Geiger T, Hirano T et al. Regulation of synthesis and secretion of major rat acute-phase proteins by recombinant human interleukin- 6 (BSF-2/IL-6) in hepatocyte primary cultures. Eur J Biochem 1988; 173: 287-293.
26. Falus A, Rokita H, Walcz E et al. Hormonal regulation of complement biosynthesis in human cell lines-II. Upregulation of the biosynthesis of complement components C3, factor B and C1 inhibitor by interleukin-6 and interleukin-1 in human hepatoma cell line. Mol Immunol 1990; 27: 197-201. (Pubitemid 20058773)
27. Anthony R, el-Omar E, Lappin DF et al. Regulation of hepatic synthesis of C3 and C4 during the acute-phase response in the rat. Eur J Immunol 1989; 19: 1405-1412. (Pubitemid 19221045)
28. Wright MS, Sund NJ, Abrahamsen TG. Modulation of C3 gene expression in HepG2 human hepatoma cells. Immunol Lett 2001; 76: 119-123. (Pubitemid 32234389)
29. Andrews E, Feldhoff P, Feldhoff R et al. Comparative effects of cytokines and cytokine combinations on complement component C3 secretion by HepG2 cells. Cytokine 2003; 23: 164-169. (Pubitemid 38340383)
30. Steel DM, Whitehead AS. Heterogeneous modulation of acutephase- reactant mRNA levels by interleukin-1 beta and interleukin- 6 in the human hepatoma cell line PLC/PRF/5. Biochem J 1991; 277: 477-482.
31. Platel D, Bernard A, Mack G et al. Interleukin 6 upregulates TNFalpha- dependent C3-stimulating activity through enhancement of TNF-alpha specific binding on rat liver epithelial cells. Cytokine 1996; 8: 895-899. (Pubitemid 27091190)
32. Fagoonee S, Gburek J, Hirsch E et al. Plasma protein haptoglobin modulates renal iron loading. Am J Pathol 2005; 166: 973-983. (Pubitemid 40524423)
33. Cid MC, Grant DS, Hoffman GS et al. Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitis. J Clin Invest 1993; 91: 977-985. (Pubitemid 23095272)
34. Matsuda T, Hirano T, Nagasawa S et al. Identification of alpha 2- macroglobulin as a carrier protein for IL-6. J Immunol 1989; 142: 148-152. (Pubitemid 19034735)
35. Serinsoz E, Bock O, Gwinner Wet al. Local complement C3 expression is upregulated in humoral and cellular rejection of renal allografts. Am J Transplant 2005; 5: 1490-1494. (Pubitemid 40839443)
36. Pratt JR, Basheer SA, Sacks SH. Local synthesis of complement component C3 regulates acute renal transplant rejection. Nat Med 2002; 8: 582-587. (Pubitemid 34633435)
37. Farrar CA, Zhou W, Lin T et al. Local extravascular pool of C3 is a determinant of postischemic acute renal failure. FASEB J 2006; 20: 217-226. (Pubitemid 44933168)
38. Arumugam TV, Shiels IA, Strachan AJ et al. A small molecule C5a receptor antagonist protects kidneys from ischemia/reperfusion injury in rats. Kidney Int 2003; 63: 134-142. (Pubitemid 35463914)
39. De Vries B, Matthijsen RA, Wolfs TG et al. Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation. Transplantation 2003; 75: 375-382. (Pubitemid 36222966)
40. Pratt JR, Hibbs MJ, Laver AJ et al. Allograft immune response with sCR1 intervention. Transpl Immunol 1996; 4: 72-75. (Pubitemid 26167067)
41. Lewis AG, Kohl G, Ma Q et al. Pharmacological targeting of C5a receptors during organ preservation improves kidney graft survival. Clin Exp Immunol 2008; 153: 117-126. (Pubitemid 351809344)
42. Takada M, Nadeau KC, Shaw GD et al. The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682-2690. (Pubitemid 27259815)
43. Zhou W, Farrar CA, Abe K et al. Predominant role for C5b-9 in renal ischemia/reperfusion injury. J Clin Invest 2000; 105: 1363-1371. (Pubitemid 30322402)
44. Brown KM, Kondeatis E, Vaughan RWet al. Influence of donor C3 allotype on late renal-transplantation outcome. N Engl J Med 2006; 354: 2014-2023.
45. Damman J, Schuurs TA, Ploeg RJ et al. Complement and renal transplantation: from donor to recipient. Transplantation 2008; 85: 923-927. (Pubitemid 351543151)
46. Naesens M, Li L, Ying L et al. Expression of complement components differs between kidney allografts from living and deceased donors. J Am Soc Nephrol 2009; 20: 1839-1851.
47. Lawrence SO, Simpson-Haidaris PJ. Regulated de novo biosynthesis of fibrinogen in extrahepatic epithelial cells in response to inflammation. Thromb Haemost 2004; 92: 234-243. (Pubitemid 39185819)
48. Haidaris PJ. Induction of fibrinogen biosynthesis and secretion from cultured pulmonary epithelial cells. Blood 1997; 89: 873-882. (Pubitemid 27121280)
49. Luyckx VA, Cairo LV, Compston CA et al. Oncostatin M pathway plays a major role in the renal acute phase response. Am J Physiol Renal Physiol 2009; 296: F875-F883.
50. Morariu AM, Schuurs TA, Leuvenink HG et al. Early events in kidney donation: progression of endothelial activation, oxidative stress and tubular injury after brain death. Am J Transplant 2008; 8: 933-941. (Pubitemid 351537757)
51. Hancock WH, Whitley WD, Tullius SG et al. Cytokines, adhesion molecules, and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643-650. (Pubitemid 23293031)
52. Rubel C, Fernandez GC, Dran G et al. Fibrinogen promotes neutrophil activation and delays apoptosis. J Immunol 2001; 166: 2002-2010. (Pubitemid 32114688)
53. Gerritsma JS, Gerritsen AF, Van Kooten C et al. Interleukin-1 alpha enhances the biosynthesis of complement C3 and factor B by human kidney proximal tubular epithelial cells in vitro. Mol Immunol 1996; 33: 847-854. (Pubitemid 27282339)
54. Brooimans RA, Stegmann AP, van Dorp WT et al. Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 1991; 88: 379-384.
55. Kolkert JL, Hart NA, van Dijk A et al. The gradual onset brain death model: a relevant model to study organ donation and its consequences on the outcome after transplantation. Lab Anim 2007; 41: 363-371 (Pubitemid 47195608)